These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Selective alpha-blockade versus angiotensin-converting enzyme inhibition as initial antihypertensive therapy. Effects on circulating lipoproteins.
    Author: Takiyyuddin MA, Cervenka JH, Dinh T, Witztum JL, O'Connor DT.
    Journal: Am J Med; 1989 Jan 23; 86(1B):32-5. PubMed ID: 2643863.
    Abstract:
    This study evaluated the overall efficacy and safety of two specific vasodilators--the alpha-blocker prazosin and the angiotensin-converting enzyme inhibitor captopril--in the treatment of mild-to-moderate essential hypertension. Because the current approach to antihypertensive treatment should consider possible drug-related changes in circulating lipid fractions, the present study investigated the effects of these two drugs on lipid parameters as well. Used either as single agents or in combination with hydrochlorothiazide, both drugs effectively reduced high blood pressure. Neither drug had adverse effects on the lipid profile in general, although there were significant differences between the effects of prazosin and captopril on total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B.
    [Abstract] [Full Text] [Related] [New Search]